VC
Vaccinex, Inc.
VCNX · OTC
$1.00 +0.00% (+$0.00)
1M -4.76%
Market Cap $2.68M
P/E Ratio -
Div. Yield -
ROE -
Piotroski F-Score Moderate
4/9Valuation
40 /100
Fair P/S 4.45x
EV/FFO N/A
P/B N/A
Growth
0 /100
Declining Rev. growth 12.59%
FCF growth N/A
Book val. growth N/A
Profitability
20 /100
Weak Net margin 3,100.50%
Op. margin 3,117.30%
FCF margin 2,696.84%
Quality
61 /100
Average ROA 717.80%
Asset turnover 0.23x
ROIC 760.66%
Debt
3 /100
High Int. coverage -620.13x
Current ratio 0.50x
Net debt/EBITDA N/A
Stability
52 /100
Moderate Rev. volatility 299.19%
EPS volatility 19.97%
Profitable years 0
Bulios Scoring popisuje kvalitu a minulost firmy, ne budoucí výnos. Vysoké skóre není nákupní signál. Zjistit více
Zeptejte se StockBota na VCNX
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Maurice Zauderer
Employees
25
Headquarters
Rochester
Nadcházející události
16 LIS
Earnings
Upcoming earnings report